• Users Online: 5449
  • Print this page
  • Email this page

  Download PDF

A multicenter, double-blind, randomized phase III trial of ramucirumab plus docetaxel versus placebo plus docetaxel for treatment of Stage IV non-small cell lung cancer after disease progression on or after platinum-based therapy (REVEL): An Indian patient subgroup analysis

Download fre pdf Download for citation manager
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here


Support open access
Recommend
Recommend this journal

 
Subscribe
Subscribe onlinePayments through